Intravenous immune globulin in chronic lymphocytic leukaemia.


The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patients. A randomized, double-blind study on 36 patients… (More)


6 Figures and Tables

Cite this paper

@article{Gamm1994IntravenousIG, title={Intravenous immune globulin in chronic lymphocytic leukaemia.}, author={Heinold Gamm and Christian Huber and Helen M. Chapel and M. Lee and F. Ries and M A Dicato}, journal={Clinical and experimental immunology}, year={1994}, volume={97 Suppl 1}, pages={17-20} }